Valneva SE (VALN) Total Debt Growth (3y) (2023 - 2026)

Valneva SE (VALN) Total Debt Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 50.25%
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 25.25%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.07%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 23.25%

Historic Data

Download Data
DateValue
Mar 31, 2026 23.25%
Dec 31, 2025 21.94%
Sep 30, 2025 16.58%
Jun 30, 2025 28.91%
Mar 31, 2025 44.75%
Dec 31, 2024 47.97%
Dec 31, 2023 49.09%